201 related articles for article (PubMed ID: 36569195)
1. Development and validation of diagnostic models for immunoglobulin A nephropathy based on gut microbes.
Dong Y; Chen J; Zhang Y; Wang Z; Shang J; Zhao Z
Front Cell Infect Microbiol; 2022; 12():1059692. PubMed ID: 36569195
[TBL] [Abstract][Full Text] [Related]
2. Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy.
Chai L; Luo Q; Cai K; Wang K; Xu B
BMC Nephrol; 2021 Jun; 22(1):209. PubMed ID: 34082732
[TBL] [Abstract][Full Text] [Related]
3. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population.
Zhong Z; Tan J; Tan L; Tang Y; Qiu Z; Pei G; Qin W
Int Immunopharmacol; 2020 Dec; 89(Pt B):107085. PubMed ID: 33068859
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota in Immunoglobulin A Nephropathy: a Malaysian Perspective.
Sugurmar ANK; Mohd R; Shah SA; Neoh HM; Cader RA
BMC Nephrol; 2021 Apr; 22(1):145. PubMed ID: 33882859
[TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study.
Hu X; Du J; Xie Y; Huang Q; Xiao Y; Chen J; Yan S; Gong Z; Ouyang S
BMC Nephrol; 2020 Mar; 21(1):97. PubMed ID: 32169051
[TBL] [Abstract][Full Text] [Related]
6. The Gut and Blood Microbiome in IgA Nephropathy and Healthy Controls.
Shah NB; Nigwekar SU; Kalim S; Lelouvier B; Servant F; Dalal M; Krinsky S; Fasano A; Tolkoff-Rubin N; Allegretti AS
Kidney360; 2021 Aug; 2(8):1261-1274. PubMed ID: 35369657
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Gut Microbiome Contributes to Barrier Dysfunction, Inflammation, and Local Immune Responses in IgA Nephropathy.
Tang Y; Xiao Y; He H; Zhu Y; Sun W; Hu P; Xu X; Liu Z; Yan Z; Wei M
Kidney Blood Press Res; 2023; 48(1):261-276. PubMed ID: 36878203
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy-Based on Mendelian Randomization and Clinical Validation.
Wang F; Li N; Ni S; Min Y; Wei K; Sun H; Fu Y; Liu Y; Lv D
Nutrients; 2023 May; 15(10):. PubMed ID: 37242290
[TBL] [Abstract][Full Text] [Related]
9. [Changes of gut microflora in newly diagnosed IgA nephropathy patients and its correlation with clinical risk factors].
Bao WH; Tang W
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 55(1):124-132. PubMed ID: 36718700
[TBL] [Abstract][Full Text] [Related]
10. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy.
Dong R; Bai M; Zhao J; Wang D; Ning X; Sun S
Front Cell Infect Microbiol; 2020; 10():557368. PubMed ID: 33194798
[TBL] [Abstract][Full Text] [Related]
11. A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity.
Han QX; Wang Y; Zhu HY; Zhang D; Gao J; Liu ZS; Cai GY; Chen XM
Chin Med J (Engl); 2019 Mar; 132(6):647-652. PubMed ID: 30855344
[TBL] [Abstract][Full Text] [Related]
12. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.
Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF
Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697
[TBL] [Abstract][Full Text] [Related]
13. Systematic Microbiome Dysbiosis Is Associated with IgA Nephropathy.
Cai F; Zhou C; Jiao N; Liang X; Ye Z; Chen W; Yang Q; Peng H; Tang Y; Niu C; Zhao G; Wang Z; Zhang G; Yu X
Microbiol Spectr; 2023 Jun; 11(3):e0520222. PubMed ID: 37227280
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies.
Han S; Shang L; Lu Y; Wang Y
Front Cell Infect Microbiol; 2022; 12():904401. PubMed ID: 35656030
[TBL] [Abstract][Full Text] [Related]
15. Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling.
Tan J; Dong L; Jiang Z; Tan L; Luo X; Pei G; Qin A; Zhong Z; Liu X; Tang Y; Qin W
J Transl Med; 2022 Aug; 20(1):382. PubMed ID: 36038927
[TBL] [Abstract][Full Text] [Related]
16. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel interplay between intestinal bacteria and metabolites in Chinese patients with IgA nephropathy via integrated microbiome and metabolome approaches.
Wu H; Tang D; Zheng F; Li S; Zhang X; Yin L; Liu F; Dai Y
Ann Transl Med; 2021 Jan; 9(1):32. PubMed ID: 33553325
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive microbiome analysis of tonsillar crypts in IgA nephropathy.
Watanabe H; Goto S; Mori H; Higashi K; Hosomichi K; Aizawa N; Takahashi N; Tsuchida M; Suzuki Y; Yamada T; Horii A; Inoue I; Kurokawa K; Narita I
Nephrol Dial Transplant; 2017 Dec; 32(12):2072-2079. PubMed ID: 27683270
[TBL] [Abstract][Full Text] [Related]
19. Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy.
Lauriero G; Abbad L; Vacca M; Celano G; Chemouny JM; Calasso M; Berthelot L; Gesualdo L; De Angelis M; Monteiro RC
Front Immunol; 2021; 12():694787. PubMed ID: 34712223
[TBL] [Abstract][Full Text] [Related]
20. Role of metabolomic profile as a potential marker to discriminate membranous nephropathy from IgA nephropathy.
Qu Y; Wang Y; Hu Z; Su C; Qian C; Pan J; Zhu Y; Shi A
Int Urol Nephrol; 2024 Feb; 56(2):635-651. PubMed ID: 37452988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
